InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (7 ops.)
Browse the complete record of transactions filed by Reumuth Mary, Chief Financial Officer. Director active across 1 companies, notably Kala Pharmaceuticals, Inc.. In total, 7 filings have been published. Total volume traded: €61k. The latest transaction was disclosed on 27 June 2022 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Declarations7 total
€9142,613 shares@ €0.34970.0059% mcap1.5% of flow
Common Stock
SEC:0001415889-22-007062:0·
€3,2782,850 shares@ €1.15020.021% mcap5.4% of flow
Common Stock
SEC:0001415889-22-000405:0·
€3,2782,850 shares@ €1.150211.0% of flow
Common Stock
SEC:0001415889-22-000405·
€14,6649,449 shares@ €1.55249.2% of flow
Common Stock
SEC:0001415889-21-005012·
€14,6649,449 shares@ €1.5520.095% mcap24.2% of flow
Common Stock
SEC:0001415889-21-005012:0·
€11,8602,452 shares@ €4.83739.8% of flow
Common Stock
SEC:0001415889-21-003259·
€11,8602,452 shares@ €4.8370.077% mcap19.6% of flow
Common Stock
SEC:0001415889-21-003259:0·
7 of 7 declarations
About Reumuth Mary
Reumuth Mary is the CHIEF FINANCIAL OFFICER of Kala Pharmaceuticals, Inc. She is responsible for the financial management of the company, including financial planning and analysis. Mary plays a key role in developing financial strategies that support Kala Pharmaceuticals' growth and profitability. Her expertise in finance is essential to ensure the company's financial health.
